Skip to main content
. 2014 Aug 29;9(8):e105792. doi: 10.1371/journal.pone.0105792

Figure 3. Growth inhibitory effects of drug treatments in MCF-7, T47D, SKBr3 and MDA-MB-231 cell line.

Figure 3

Cells were treated with trametinib, everolimus, NVP-BEZ235 or GSK2126458 for 3 days and [3H]-thymidine added for the last 6 hours. Results are shown as the mean ± standard error from duplicate experiments.